Trial Profile
Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Embolism and thrombosis; Migraine
- Focus Therapeutic Use
- Acronyms CANOA
- 09 Nov 2015 Primary endpoint has been met. (Mean number of monthly migraine days per patient within the 3 months following transcatheter ASD closure.)
- 09 Nov 2015 Results published in the JAMA: the Journal of the American Medical Association
- 09 Nov 2015 Status changed from active, no longer recruiting to completed, according to results published in JAMA.